CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 33 enrolled
Drug / intervention
Dexamethasone infusion +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02807779
NCT02807779Phase 4Completed

Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

University of California, San Francisco·interventional·Posted Jun 21, 2016·Updated Jul 17, 2025

In Brief

A Phase 4 clinical trial evaluating Dexamethasone infusion, Drug coated balloon, and 1 other intervention for Peripheral Artery Disease and 2 related conditions. Completed, enrolled 33 participants across 2 sites.

Detailed Summary

This is a prospective, multicenter, randomized trial to determine the mechanisms of vascular healing. The study will evaluate subjects with peripheral artery disease (PAD) who require an endovascular intervention of the femoro-popliteal (SFA) artery to restore blood flow to the leg.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 21, 2016
Enrollment StartFeb 10, 2016
Primary CompletionOct 31, 2020
Study CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 10.0 years ago

Interventions

Dexamethasone infusiondrug

Participants will receive dexamethasone infusion following plain balloon angioplasty

Drug coated balloondevice

Participants will receive angioplasty with a drug-coated balloon following plain balloon angioplasty

Plain balloon angioplastydevice

Participants will receive plain balloon angioplasty only